Blog

The more I read about patient centricity, the more I get the eerie feeling that there is something wrong, something missing. At first glance the concept is very clear, the strategy and tactics are right and the tools put to use all have an added value. But it still doesn’t feel quite right to me. So what is it? Being responsible for business development, I fully understand why the...Read more

When reading about patient centricity one might get the impressions that technology will make it all happen. A lot of money is spent on portal solutions to make trial information more accessible for patients, and on mobile apps that will make it easier for patients to share the information the industry needs from them. But looking at these solutions the question pops to mind how all of this will...Read more

According to data published by Zenithoptimedia, between 2010 and 2014 the average time people spent online grew from 60 to 110 minutes per day. At the same time newspaper and magazine consumption dropped by 26% and 19%, respectively. You will find more statistics at Statista   Moreover, according to a study by Reuters Institute for the Study of Journalism very few people consider print...Read more

This year’s Clinical Trials Innovation Program (CTIP) will be held in Frankfurt on 22-23 October 2015. The CTIP is an exclusive, invitation only event and each year helps senior executives from Pharma & Biotech industries to forge strong and lasting business relationships and to share best practice and knowledge about the very latest issues affecting the industry.  The event will...Read more

Recently the National Cancer Institute in the US has published a concise and easy to read step-by-step guide for cancer patients who are looking for clinical trials. Each of the ten steps in the guide explains in simple terms what to do and if applicable where to find more detailed information.  The guide not only provides links to multiple sources containing information about ongoing and...Read more

The roundtable discussion we facilitated in London last month, made us aware that there still is a lot of misunderstanding and concerns in the pharmaceutical industry about using social media as an effective tool for patient recruitment and patient centricity.  We also learned that there is a lot of interest for informal and interactive discussions with peers about this particular subject,...Read more

At last month’s Proventa 2015 Clinical Data Strategy Meeting in London, Link2Trials’ Managing Director Simon Klaasen facilitated a successful round-table discussion about the pros and cons of using social media for patient recruitment and how it can boost patient centricity.  Twenty delegates from 15 different pharmaceutical companies attended the round-table and during a lively...Read more

It seems that nowadays patient centricity is a hot topic for everyone in the life science industry. Many articles are written about patient centricity, and more and more events and conferences use it as the main subject. But will the industry feel the same way about patient centricity a few years from now, or will it be discarded as just a lot of hot air? We believe it is not and that it is the...Read more

On July 1, 2015 Link2Trials will attend the Clinical Data Strategy Meeting Europe 2015 in London. Simon Klaasen will facilitate a roundtable discussion about patient centricity, social media and patient recruitment based on the following statements: Patient centricity, engagement and empowerment will increase patient participation in clinical trials Social media can be a very efficient tool...Read more

Reasons for Change It has all been said before: Over 95% of the clinical studies fail to meet their original time lines and budgets[1] and that one day of delay could cost a sponsor $1.6 million on averaged lost revenue.[2] Between 2006 and 2016 the global spending on drug development will grow from $108 billion to over $148 billion.[3] Clinical trials account for 45% to 75% of this cost[4] and...Read more